facebook pixeldeprexis® | Utilize Artificial Intelligence And CBT-based Techniques
Skip to content (Press Enter)

Discover the deprexis experience

Two illustrated women walking their dogs among the flowers
decorative image

Responsive to you

deprexis® asks you questions and tailors responses based on your answers, creating therapy personalized to you.1

decorative image

Topics centered
around you

deprexis® has 10 content modules that focus on how you're actively feeling.2,3

decorative image

Advance on
your terms

Access to deprexis® lasts
12 weeks—use based on your schedule. Modules take between 10-60 minutes depending on your pace.2,4

decorative image

Fits into your lifestyle

As long as you have internet access, deprexis® is available anywhere. Whenever you need to connect, just log in.5

deprexis® is a proven complement to other depression therapies 2,3

a woman looking at her computer
deprexis® offers the flexibility to fit with any existing treatment plan.
Experience the 10 proven modules of deprexis®

Get deprexis® now

Get started by purchasing deprexis®

start deprexis®
Have questions
about deprexis®?
References
  • 1. Meyer B, Bierbrodt J, Schröder J, et al. Effects of an internet intervention (deprexis) on severe depression symptoms: randomized controlled trial. Internet Intervent. 2015;2(1):48-59.
  • 2. Beevers CG, Pearson R, Hoffman JS, et al. Effectiveness of an internet intervention (deprexis) for depression in a United States adult sample: a parallel-group pragmatic randomized controlled trial. J Consult Clin Psychol. 2017;85(4):367-380.
  • 3. Meyer B, Berger T, Caspar F, et al. Effectiveness of a novel integrative online treatment for depression (deprexis): randomized controlled trial. J Med Internet Res. 2009;11(2):e15.
  • 4. Klein JP, Berger T, Schröder J, et al. Effects of a psychological internet intervention in the treatment of mild to moderate depressive symptoms: results of the EVIDENT study, a randomized controlled trial. Psychother Psychosom. 2016;85(4):218-228.
  • 5. Orexo acquires exclusive US rights to commercialize deprexis®, a world-leading digital therapy to help patients manage the symptoms of depression. News release. Orexo AB (publ.). May 11, 2020. Accessed March 11, 2021. https://orexo.com/investors/regulatory-press-releases/2020-05-11-orexo-acquires-exclusive-us-rights-to-commercialize-deprexis-a-world-leading-digital-therapy-to-help-patients-manage-the-symptoms-of-depression

deprexis® is not a healthcare provider and does not provide medical advice, diagnosis, or standalone treatment. If you need immediate medical attention, please contact your healthcare provider or go to the closest emergency room.